Advertisement

Topics

China Cord Blood Corporation Company Profile

00:01 EDT 20th September 2017 | BioPortfolio

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with multiple licenses. Under the current PRC government regulations, only one licensed cord blood bank operator is permitted to operate in each licensed region and only six licenses have been issued as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com .


News Articles [3219 Associated News Articles listed on BioPortfolio]

China Cord Blood Corporation Announces Participation in the 31st Annual J.P. Morgan Healthcare Conference

HONG KONG, Dec. 27, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE:CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced that th...

China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results

HONG KONG, Feb. 19, 2013 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the third quarter an...

China Cord Blood Corporation to Report First Quarter Fiscal 2018 Financial Results

HONG KONG, Aug. 17, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release its preliminary unaudited first quarter fiscal 2018 financial ...

China Cord Blood Corporation Continues Share Repurchase Program

HONG KONG, Oct. 22, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE:CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, today announced...

China Cord Blood Corporation to Report Fourth Quarter and Full Year of Fiscal 2017 Financial Results

Earnings Call Scheduled for 8:00 a.m. ET on June 22, 2017 HONG KONG, June 14, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to ...

China Cord Blood Corporation Announces Adoption of 10b5-1 Sales Plan

HONG KONG, Aug. 28, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that Magnum Opus Second (PTC) Limited, an entity holding ordinary shares on behalf of c...

Banking a Baby’s Cord Blood May Save Their Life. Is It Worth It?

(New Scientist) – IT IS only half a cup of blood, but it could change your life. Blood taken from a newborn baby’s umbilical cord is a rich source of uniquely potent stem cells. Parents are of...

China Cord Blood (CO) Q4 2017 Results - Earnings Call Transcript

PubMed Articles [4533 Associated PubMed Articles listed on BioPortfolio]

Effect of season of birth on cord blood IgE and IgE at birth: A systematic review and meta-analysis.

Elevated cord blood IgE is important on the pathway to allergic disease. The association between season of birth and infant cord blood IgE is not well-established. Study findings differ on which birth...

Cord blood neutropenia is an independent predictor of early sepsis.

The significance of cord blood neutropenia as a screening tool for early-onset sepsis (EOS) is unclear. The objectives were to define reference values for cord blood neutrophil count and to determine ...

Cord Blood Metabolome Is Highly Associated with Birth Weight, but Less Predictive for Later Weight Development.

Fetal metabolism may be changed by the exposure to maternal factors, and the route to obesity may already set in utero. Cord blood metabolites might predict growth patterns and later obesity. We aimed...

Can venous cord gas values predict fetal acidemia?

Umbilical cord arterial blood gas values are used to diagnose fetal acidemia, however arterial cord blood specimens are frequently not available.

Sertraline in pregnancy - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood.

This study is the first to measure and correlate sertraline concentrations in maternal blood, amniotic fluid and umbilical cord blood and account for distribution of the drug between these three compa...

Clinical Trials [4244 Associated Clinical Trials listed on BioPortfolio]

A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy

In this study two cord blood collections will be used to increase the number of cord blood cells you will receive on transplant day. We call this a "double unit" cord blood transplant. A p...

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

The National Marrow Donor Program (NMDP) has established a system for registering, matching, and tracking unrelated donor cord blood units (CBUs) and transplant outcomes. Study subjects a...

Transplants With Unlicensed Preserved Cord Blood

Background: - Cord blood transplants can treat cancers and other diseases in children and adults. The U.S. Food and Drug Administration (FDA) requires cord blood to be collected and store...

Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers

This study is to evaluate the safety of transplantation of two cord blood products, including toxicities in patients following high-dose, myeloablative chemotherapy for blood malignancies....

Phase I Study of Sequential Cord Blood Transplants

The purpose of this study is to determine the safety of sequential cord blood transplantation (2 cord blood units) for patients who have diseases that are capable of being cured by allogen...

Companies [1389 Associated Companies listed on BioPortfolio]

China Cord Blood Corporation

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with multiple licenses. Un...

Cord Blood America, Inc.

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected ste...

Cleveland Cord Blood Center

Following the delivery of a full-term newborn and collection of cord blood, a CCBC nurse collection coordinator at each hospital ensures that the cord blood is safely transported to the CCBC's 5,000 s...

Nohla Therapeutics Inc.

Nohla’s goal is to transform the medical care options for patients with our expanded cord blood product. The proprietary expansion platform multiplies the number of stem cell...

Cord Blood America

Cord Blood America's mission is to be the most respected stem cell preservation company in the world. Cord Blood America will achieve its mission through educating expectant parents, families with a h...

More Information about "China Cord Blood Corporation" on BioPortfolio

We have published hundreds of China Cord Blood Corporation news stories on BioPortfolio along with dozens of China Cord Blood Corporation Clinical Trials and PubMed Articles about China Cord Blood Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of China Cord Blood Corporation Companies in our database. You can also find out about relevant China Cord Blood Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record